Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pharmaceutical Care Management Association
PCMA: Time is Now for Policymakers to Create Clear Regulatory Pathway for Biogenerics
April 11th, 2007
With increasing momentum being generated for passage of legislation that would create a clear regulatory pathway for follow-on biologics, or "biogenerics," the Pharmaceutical Care Management Association (PCMA) believes the time to act is now in creating much-needed competition in this space. In February, PCMA was joined by a number of influential consumer, employer, and insurer groups who endorsed the "Access to Life Saving Medicine Act of 2007," bipartisan legislation that seeks to create a clear regulatory pathway for biogenerics. Today, the House Oversight and Government Reform Committee is holding hearings on this issue, while earlier this month, the US Senate...
Source: Medical Patent Law Weekly (2007-04-11)
|
